Novartis stops HCQ trial against COVID-19 citing participant shortfall
The move comes in the wake of US FDA’s decision to EUA for hydroxychloroquine and chloroquine against COVID-19
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.